New Wosulin 30 /70 40 Iu ( 15 Ml )

NEW WOSULIN 30/70 40 IU (15 ML) by WOCKHARDT LIMITED

New Wosulin 30/70 40IU/ml Injection is an insulin preparation from Wockhardt Ltd. that helps manage blood sugar levels in individuals with diabetes.

• Name: NEW WOSULIN 30/70 40IU/ml Injection (Brand: New Wosulin).
• Composition: It is a biphasic premixed insulin formulation containing Human Insulin (30% soluble/rapid-acting) and Insulin Isophane/NPH (70% intermediate-acting) at a strength of 40 IU/ml.
• Uses: This medicine is prescribed for the treatment of both Type 1 and Type 2 Diabetes Mellitus. It works by suppressing the production of sugar in the liver and promoting the reuptake of sugar into fat and muscle cells, thereby maintaining consistent blood sugar control throughout the day. It also helps reduce the risk of diabetes complications such as kidney damage, eye damage, and nerve problems.
• Dosage and Administration: New Wosulin 30/70 is administered subcutaneously (under the skin) in areas like the abdomen, thigh, buttocks, or upper arm. Injection sites should be rotated to prevent skin issues. It is typically taken 15 to 30 minutes before a meal, or within 20 minutes after starting a meal, followed by a carbohydrate-containing meal. The dosage is highly individualized and determined by a physician. This medication should never be administered intravenously.
• Side Effects: Common side effects include low blood sugar (hypoglycemia), injection site reactions (pain, swelling, redness, itching), weight gain, edema (fluid retention), and skin thickening or pits at the injection site (lipodystrophy). Serious but less common side effects can include hypokalemia (low potassium levels) or, rarely, heart failure when used with pioglitazone in high-risk patients.
• Precautions: Alcohol consumption should be avoided as it can affect blood glucose levels. Caution is advised for patients with kidney, liver, or heart conditions, and dose adjustments may be necessary. Driving or operating machinery should be done with caution due to the risk of hypoglycemia.
• Storage: New Wosulin 30/70 is a cold chain medicine. Unopened vials must be stored in a refrigerator between 2°C and 8°C and should not be frozen. Once opened, the vial can be stored at room temperature (below 25°C to 30°C) for up to 28 days. Keep away from direct light and out of reach of children.

NEW WOSULIN 30/70 40 IU (15 ML) by WOCKHARDT LIMITED: Frequently Asked Questions

NEW WOSULIN 30/70 is a type of insulin medication used to manage blood sugar levels in individuals with diabetes. This premixed insulin combines both rapid-acting and intermediate-acting insulin to provide comprehensive glucose control.

What is NEW WOSULIN 30/70 used for?

NEW WOSULIN 30/70 is primarily used for the treatment of both Type 1 and Type 2 diabetes mellitus in adults and children. It helps to improve blood sugar control and prevent complications associated with diabetes, such as damage to the retina (retinopathy), kidneys (nephropathy), and nerves (neuropathy). It can also be used for the management of gestational diabetes and for initial stabilization during diabetic ketoacidosis or hyperosmolar non-ketotic syndrome, and stressful periods like severe infections or major surgery.

How does NEW WOSULIN 30/70 work?

NEW WOSULIN 30/70 is a combination of two types of insulin: 30% rapid-acting human insulin and 70% intermediate-acting isophane insulin. The rapid-acting component quickly lowers blood glucose levels after meals, while the intermediate-acting component provides a longer-lasting effect to control blood sugar between meals and overnight. Insulin works by facilitating the uptake of glucose into muscle and fat cells and by suppressing the production of glucose by the liver, thus lowering blood sugar levels.

What is the usual dosage of NEW WOSULIN 30/70?

The dosage of NEW WOSULIN 30/70 is individualized and determined by a physician based on the patient's specific needs, blood glucose monitoring results, diet, and activity level. It is typically administered subcutaneously (under the skin) in areas like the abdominal wall, thigh, gluteal region, or deltoid region, with injection sites rotated frequently to avoid lipodystrophy. It is generally advised to administer the injection 15 to 30 minutes before a meal. Using the correct syringe strength (e.g., U-40 or U-100) is crucial to avoid dosage errors.

What are the possible side effects of NEW WOSULIN 30/70?

The most common side effect is hypoglycemia (low blood sugar), which can manifest as lightheadedness, dizziness, anxiety, nervousness, tiredness, hunger, visual disturbances, headache, shaking, sweating, and pale skin. Other possible side effects include allergic reactions at the injection site (redness, pain, swelling, itching), lipodystrophy (skin thickening or pits at the injection site), edema (swelling), rashes, and weight gain.

Is NEW WOSULIN 30/70 safe during pregnancy or breastfeeding?

Yes, NEW WOSULIN 30/70 is generally considered safe for use during pregnancy as insulin does not cross the placental barrier. However, close monitoring of blood sugar levels is recommended, as insulin requirements may change throughout pregnancy. It is also considered safe for use by breastfeeding mothers, although a dose adjustment may be required, and it's advisable to consult a doctor.

Can NEW WOSULIN 30/70 be taken with other medications?

Insulin requirements can be affected by other medications. Some drugs may increase insulin needs (e.g., corticosteroids, oral contraceptives, thyroid replacement therapy), while others may decrease them, leading to a higher risk of hypoglycemia (e.g., oral hypoglycemic agents, salicylates, sulfa antibiotics, certain antidepressants, ACE inhibitors, beta-blockers). Beta-blockers can also mask the symptoms of hypoglycemia. It is crucial to inform your doctor about all current medications to ensure proper dose adjustments and to avoid potential interactions.

What precautions should be taken with NEW WOSULIN 30/70?

It is important to avoid injecting into areas where the skin is tender, red, bruised, hard, scarred, or has stretch marks. Patients should rotate injection sites to prevent lipodystrophy. Never share the insulin vial or syringe with others. Be cautious when driving or operating machinery, as insulin can cause low blood sugar levels, impairing concentration and reaction time. Alcohol consumption is generally not recommended as it can interfere with insulin's action and cause fluctuations in blood glucose. Special care should be taken in patients with kidney, liver, or heart problems, and dose adjustments may be necessary.

What happens if a dose of NEW WOSULIN 30/70 is missed?

If a dose is missed, it can lead to increased blood sugar levels (hyperglycemia). You should check your blood sugar level as soon as you realize you missed a dose. If it's close to the time for your next scheduled dose, skip the missed one and continue with your regular schedule. Do not take a double dose to compensate, as this can cause a dangerous drop in blood glucose. Always follow your doctor's instructions regarding missed doses.

How should NEW WOSULIN 30/70 be stored?

NEW WOSULIN 30/70 should be stored in a refrigerator at temperatures between 2°C and 8°C (36°F and 46°F) and must not be frozen. Insulin preparations that have been frozen must not be used. Once opened, vials can be kept at room temperature (15°C to 25°C or 59°F to 77°F) for up to six weeks. It should be protected from excessive heat and direct sunlight and kept out of reach of children.